BBIO logo

BridgeBio Pharma, Inc. (BBIO) return on equity

annual ROE:

37.02%-11.22%(-23.26%)
December 31, 2024

Summary

  • As of today (September 14, 2025), BBIO annual return on equity is 37.02%, with the most recent change of -11.22% (-23.26%) on December 31, 2024.
  • During the last 3 years, BBIO annual ROE has fallen by -30.36% (-45.06%).
  • BBIO annual ROE is now -51.00% below its all-time high of 75.55%, reached on December 31, 2017.

Performance

BBIO ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOprofitability metrics

quarterly ROE:

51.19%+1.42%(+2.85%)
June 30, 2025

Summary

  • As of today (September 14, 2025), BBIO quarterly return on equity is 51.19%, with the most recent change of +1.42% (+2.85%) on June 30, 2025.
  • Over the past year, BBIO quarterly ROE has increased by +11.95% (+30.45%).
  • BBIO quarterly ROE is now -84.84% below its all-time high of 337.56%, reached on June 30, 2021.

Performance

BBIO quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

BBIO ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-23.3%+30.4%
3 y3 years-45.1%-8.9%
5 y5 years+154.7%+140.2%

BBIO ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-45.1%at low-8.9%+39.5%
5 y5-year-45.1%+121.4%-84.8%+112.8%
alltimeall time-51.0%+121.4%-84.8%+106.1%

BBIO ROE History

DateAnnualQuarterly
Jun 2025
-
51.19%(+2.9%)
Mar 2025
-
49.77%(+10.8%)
Dec 2024
37.02%(-23.3%)
44.90%(+18.9%)
Sep 2024
-
37.77%(-3.7%)
Jun 2024
-
39.24%(-10.8%)
Mar 2024
-
43.97%(-13.3%)
Dec 2023
48.24%(+24.9%)
50.74%(+2.7%)
Sep 2023
-
49.39%(+5.3%)
Jun 2023
-
46.92%(+27.8%)
Mar 2023
-
36.70%(-15.6%)
Dec 2022
38.63%(-42.7%)
43.47%(-10.8%)
Sep 2022
-
48.72%(-13.3%)
Jun 2022
-
56.21%(-28.9%)
Mar 2022
-
79.09%(-16.6%)
DateAnnualQuarterly
Dec 2021
67.38%(-138.9%)
94.84%(-35.6%)
Sep 2021
-
147.36%(-56.3%)
Jun 2021
-
337.56%(-184.6%)
Mar 2021
-
-398.80%(+149.6%)
Dec 2020
-173.15%(+156.0%)
-159.78%(+40.5%)
Sep 2020
-
-113.76%(-10.7%)
Jun 2020
-
-127.33%(-19.9%)
Mar 2020
-
-159.01%(-22.3%)
Dec 2019
-67.64%(-35.6%)
-204.56%(-75.6%)
Sep 2019
-
-837.23%(-442.6%)
Jun 2019
-
244.38%(-173.0%)
Mar 2019
-
-334.67%(+776.6%)
Dec 2018
-105.03%(-239.0%)
-38.18%
Dec 2017
75.55%
-

FAQ

  • What is BridgeBio Pharma, Inc. annual return on equity?
  • What is the all time high annual ROE for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. annual ROE year-on-year change?
  • What is BridgeBio Pharma, Inc. quarterly return on equity?
  • What is the all time high quarterly ROE for BridgeBio Pharma, Inc.?
  • What is BridgeBio Pharma, Inc. quarterly ROE year-on-year change?

What is BridgeBio Pharma, Inc. annual return on equity?

The current annual ROE of BBIO is 37.02%

What is the all time high annual ROE for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high annual return on equity is 75.55%

What is BridgeBio Pharma, Inc. annual ROE year-on-year change?

Over the past year, BBIO annual return on equity has changed by -11.22% (-23.26%)

What is BridgeBio Pharma, Inc. quarterly return on equity?

The current quarterly ROE of BBIO is 51.19%

What is the all time high quarterly ROE for BridgeBio Pharma, Inc.?

BridgeBio Pharma, Inc. all-time high quarterly return on equity is 337.56%

What is BridgeBio Pharma, Inc. quarterly ROE year-on-year change?

Over the past year, BBIO quarterly return on equity has changed by +11.95% (+30.45%)
On this page